Annual ROE
-127.64%
-12.48%-10.84%
December 31, 2023
Summary
- As of February 7, 2025, OCUL annual return on equity is -127.64%, with the most recent change of -12.48% (-10.84%) on December 31, 2023.
- During the last 3 years, OCUL annual ROE has risen by +301.91% (+70.29%).
- OCUL annual ROE is now -522.09% below its all-time high of 30.24%, reached on December 31, 2012.
Performance
OCUL ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-70.49%
+7.44%+9.55%
September 30, 2024
Summary
- As of February 7, 2025, OCUL quarterly return on equity is -70.49%, with the most recent change of +7.44% (+9.55%) on September 30, 2024.
- Over the past year, OCUL quarterly ROE has increased by +257.39% (+78.50%).
- OCUL quarterly ROE is now -102.40% below its all-time high of 2939.06%, reached on September 30, 2020.
Performance
OCUL Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
OCUL ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -10.8% | +78.5% |
| 3 y3 years | +70.3% | +48.5% |
| 5 y5 years | +34.0% | +77.0% |
OCUL ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -1497.5% | at low | -793.4% | +78.5% |
| 5 y | 5-year | -1497.5% | +76.2% | -102.4% | +98.5% |
| alltime | all time | -522.1% | +76.2% | -102.4% | +98.5% |
Ocular Therapeutix ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -70.49%(-9.5%) |
| Jun 2024 | - | -77.93%(-29.7%) |
| Mar 2024 | - | -110.88%(-59.6%) |
| Dec 2023 | -127.64%(+10.8%) | -274.31%(-16.3%) |
| Sep 2023 | - | -327.88%(+15.8%) |
| Jun 2023 | - | -283.16%(+51.1%) |
| Mar 2023 | - | -187.44%(+66.3%) |
| Dec 2022 | -115.16%(+1341.3%) | -112.69%(+39.4%) |
| Sep 2022 | - | -80.82%(+99.5%) |
| Jun 2022 | - | -40.51%(+52.8%) |
| Mar 2022 | - | -26.52%(+236.1%) |
| Dec 2021 | -7.99%(-98.1%) | -7.89%(-94.2%) |
| Sep 2021 | - | -136.73%(-36.0%) |
| Jun 2021 | - | -213.55%(-51.1%) |
| Mar 2021 | - | -436.50%(-64.6%) |
| Dec 2020 | -429.55%(-19.8%) | -1234.74%(-142.0%) |
| Sep 2020 | - | 2939.06%(-160.6%) |
| Jun 2020 | - | -4846.19%(+230.2%) |
| Mar 2020 | - | -1467.75%(+163.2%) |
| Dec 2019 | -535.72% | -557.58%(+81.6%) |
| Sep 2019 | - | -307.09%(+33.7%) |
| Jun 2019 | - | -229.73%(+46.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | -156.81%(+5.9%) |
| Dec 2018 | -193.41%(+19.2%) | -148.13%(+7.7%) |
| Sep 2018 | - | -137.48%(+0.2%) |
| Jun 2018 | - | -137.16%(+0.2%) |
| Mar 2018 | - | -136.95%(-2.3%) |
| Dec 2017 | -162.21%(+156.9%) | -140.23%(+16.5%) |
| Sep 2017 | - | -120.36%(+25.0%) |
| Jun 2017 | - | -96.29%(+26.9%) |
| Mar 2017 | - | -75.85%(+20.3%) |
| Dec 2016 | -63.14%(+17.8%) | -63.05%(+19.0%) |
| Sep 2016 | - | -52.97%(+6.8%) |
| Jun 2016 | - | -49.59%(-0.9%) |
| Mar 2016 | - | -50.04%(+2.8%) |
| Dec 2015 | -53.61%(+9.8%) | -48.68%(+0.9%) |
| Sep 2015 | - | -48.23%(-36.5%) |
| Jun 2015 | - | -75.99%(-38.6%) |
| Mar 2015 | - | -123.72%(-94.4%) |
| Dec 2014 | -48.81%(-318.0%) | -2190.88%(-1280.6%) |
| Sep 2014 | - | 185.58%(+256.6%) |
| Jun 2014 | - | 52.04%(-26.6%) |
| Mar 2014 | - | 70.87%(+216.5%) |
| Dec 2013 | 22.39%(-26.0%) | 22.39% |
| Dec 2012 | 30.24% | - |
FAQ
- What is Ocular Therapeutix annual return on equity?
- What is the all time high annual ROE for Ocular Therapeutix?
- What is Ocular Therapeutix annual ROE year-on-year change?
- What is Ocular Therapeutix quarterly return on equity?
- What is the all time high quarterly ROE for Ocular Therapeutix?
- What is Ocular Therapeutix quarterly ROE year-on-year change?
What is Ocular Therapeutix annual return on equity?
The current annual ROE of OCUL is -127.64%
What is the all time high annual ROE for Ocular Therapeutix?
Ocular Therapeutix all-time high annual return on equity is 30.24%
What is Ocular Therapeutix annual ROE year-on-year change?
Over the past year, OCUL annual return on equity has changed by -12.48% (-10.84%)
What is Ocular Therapeutix quarterly return on equity?
The current quarterly ROE of OCUL is -70.49%
What is the all time high quarterly ROE for Ocular Therapeutix?
Ocular Therapeutix all-time high quarterly return on equity is 2939.06%
What is Ocular Therapeutix quarterly ROE year-on-year change?
Over the past year, OCUL quarterly return on equity has changed by +257.39% (+78.50%)